Welcoming CDC director Jim O'Neal is calling on vaccine makers to split up the combined MMR vaccine. In a post on X yesterday, O'Neal endorsed President Trump's earlier call to split the measles, MS, and Reubella vaccine into three separate injections. The post came just hours after O'Neal signed off on a vaccine advisory panel recommendation against getting the vaccine before the age of four.Let's bring in NBC News medical contributor Dr. . Vin Gupta. Uh so doctor, what would be the problem with this sugge ...

Well, today the CDC put out new guidance that could make it harder for a lot of kids and adults to get an updated CO 19 booster this season. In fact, people younger than 65 are now recommended to consult with a doctor or even a pharmacist before getting their vaccination. But experts warned that this change could limit access to the shot and compromise herd immunity in states that follow this new recommendation.Joining us now for more clarity, NBC News health and medical reporter Erica Edwards. Erica, what ...

A mercury-containing preservative that is used in some vaccines has not been used in childhood vaccines since 2001, according to the Despite his concerns about childhood vaccines, Hill would not support new restrictions on them while more research is conducted. "If there are people that want it, I think it should be available to them," said Hill, a supervisor at a nuclear power plant. "While you're studying, let be available." Hill is one of 20 Americans who voted for President Donald Still, each of thes ...

60 Minutes overtime. Reporting on vaccine injuries is a complicated topic, and it's important to continuously remember the incredible lifesaving power of vaccines. Over 150 million lives have been saved worldwide due to vaccines.I'm Denise Shrier Chedetta and I'm a producer at 60 Minutes in Washington DC within the US Court of Federal Claims. This week on 60 Minutes, we report on the vaccine court, a littleknown court that Congress founded in the 80s and has been compensating Americans injured by vaccines f ...

Summary of Cardinal Health 2025 Conference Call Company Overview - **Company**: Cardinal Health (NYSE: CAH) - **Industry**: Healthcare Supply Chain - Cardinal Health operates across the entire U.S. healthcare supply chain, connecting innovators, manufacturers, and patients, with a significant focus on pharmaceutical and specialty solutions, which account for over $200 billion of the total $220 billion in revenue [4][6]. Core Business Segments - **Pharmaceutical and Specialty Solutions**: The cornerstone of Cardinal Health's operations, contributing significantly to revenue and profitability [4][5]. - **Growth Businesses**: Includes Nuclear & Precision Health Solutions, At-Home Solutions, and OptiFreight® Logistics, which are positioned for growth due to unique market trends [5][6]. - **Global Medical Products and Distribution (GMPD)**: A turnaround business that has improved profitability after previous losses due to inflation and tariffs [6][10]. Financial Performance and Guidance - Cardinal Health achieved an 18% growth in earnings per share (EPS), exceeding the previously projected 12% to 14% growth [9][14]. - Long-term growth plans include generating adjusted free cash flow of at least $10 billion and maintaining a solid balance sheet with a BBB rating [18][19]. - The company plans to return $750 million to shareholders and maintain a growing dividend, emphasizing its status as a dividend aristocrat [18][19]. Strategic Initiatives - **Investor Day Takeaways**: Focus on accountability, performance measurement, and strategic evolution across five operating segments [8][10]. - **Investment in Technology**: Cardinal Health is investing in automation and technology to enhance operational efficiency, including refreshing distribution centers [12][46]. - **Acquisitions**: Recent acquisitions, such as Solaris in the urology space, are aimed at expanding capabilities and driving growth in specialty services [15][30]. Market Trends and Demand - Strong demand in the pharmaceutical and specialty solutions business is driven by procedures and scripts, with expectations of continued growth despite potential normalization in industry growth trends [21][20]. - The company anticipates a slight headwind from COVID vaccine contributions compared to previous years, but overall demand remains strong [27][29]. Management Services Organization (MSO) Strategy - Cardinal Health is focusing on acquiring practices in fragmented markets like autoimmune and urology, with a goal to create scale and provide comprehensive services to physicians [30][35]. - The MSO strategy aims to consolidate independent practices, providing them with back-office support and technology to enhance operational efficiency [31][40]. Challenges and Risks - Potential impacts from drug pricing policies and tariffs are acknowledged, but Cardinal Health believes it is well-positioned to manage these risks due to its diverse revenue streams and operational model [43][49]. - The company is cautious about the evolving landscape of generics, with expectations of increased contributions from generics over the next few years due to higher loss of exclusivity (LOE) [51][54]. Conclusion - Cardinal Health is strategically positioned for growth with a focus on its core pharmaceutical and specialty solutions business, while also expanding its presence in high-growth areas through acquisitions and investments in technology. The company remains committed to delivering value to shareholders while navigating industry challenges and market dynamics.

Vaccine Policy & Public Health - A federal panel's new rules for COVID shots could reduce vaccine availability [1] - The Advisory Committee on Immunization Practices (ASIP) recommended that individuals under 65 consult a doctor before receiving the COVID vaccine, differing from previous recommendations for all Americans aged 6 months and older [2] - The panel also voted to restrict the use of the MMRV vaccine, advising against its use for children under four years old [2][3] - Childhood vaccination rates have been declining, leading to nearly 1,500 documented measles cases in the US this year, the highest level in over 25 years [10] Historical Context & Impact of Vaccines - In 1900, the US life expectancy was 473%, significantly lower than today's 784% due to infant and child mortality from preventable diseases [5][6] - Before the introduction of the measles vaccine in the early 1960s, the US saw 3 to 4 million measles cases annually, with 400 to 500 deaths [8] - Measles deaths declined by 90% in the decade after the introduction of measles vaccines, and measles was considered eliminated in the US in 2000 [9] - Vaccines are considered a top innovation for contributing to health, longevity, and overall human well-being [14] Skepticism vs Pseudoscience & Public Trust - The discussion around vaccines is not solely scientific, as panels are now populated with vaccine critics, some of whom have profited from that position [16] - It's important to distinguish legitimate skepticism, which is part of science, from pseudoscience, as public trust and polarization are key issues [17][19] - Herd immunity is crucial, and decreased vaccination rates can affect many people [21][22] - Vaccination is a public health issue and a shared responsibility for the safety and health of the community [22][23]

iter for the average American to get an updated COVID vaccine. On Friday, a CDC advisory panel unanimously recommended limiting the COVID shot to people 65 and older or those with underlying health conditions. This days after the former CDC chief medical officer, Dr.. Deborah Howry, warned Congress about changes in the AY's decision-making process. I resigned because CDC leaders were reduced to rubber stamps. supporting policies not based in science, and putting American lives at risk.Secretary Kennedy cens ...

You'd think that by the end of an 8-h hour meeting, you might have some idea of what you and your colleagues are actually voting on. Apparently, the CDC's new vaccine advisory committee, handpicked by Robert F. Kennedy Jr.., never got that memo. I'm still not quite clear. So, if we um the first vote has passed already and if we vote no on this item, then what happens.Body and I share the same confusion here. Okay, I'm going to abstain because I'm not quite sure what I'm voting for here. We are rookies and u ...

COVID Vaccine Recommendations - CDC's vaccine advisory panel made COVID shot recommendation an individual decision, preferably with a doctor [1] - The panel's vote was contentious, requiring the chair to break a tie [1] - The panel opted not to recommend states require a prescription for the shot [2] - Government providers and private insurers will continue to cover the COVID vaccines [2] - The panel was handpicked by a vaccine skeptic, potentially causing states to diverge from recommendations [2][3] - The varying guidelines may cause confusion for the general public regarding COVID vaccine decisions [3] Hepatitis B Vaccine - Proposed changes to the hepatitis B vaccine for newborns were tabled [4] - Concerns were raised regarding a lack of science and data about potential side effects [4] - More discussion is needed regarding the hepatitis B vaccine [4]

Vaccine Recommendations & Guidelines - CDC's vaccine advisory panel voted to make COVID shot an individual decision, preferably with a doctor, instead of recommending it for all adults [1] - The panel opted not to recommend that states require a prescription for the COVID shot [1] - Softer recommendations for vaccines may lead to decreased uptake as patients may perceive them as less important [2] - Some states may break from the panel's recommendations, potentially creating inconsistent guidelines across the country and causing public confusion [3] Vaccine Coverage & Availability - Government providers and private insurers are expected to continue covering COVID vaccines [2] - CVS, a major pharmacy chain, plans to allow online appointments and walk-ins for COVID shots at its stores and clinics, pending CDC director approval [5] Hepatitis B Vaccine - Proposed changes to the hepatitis B vaccine for newborns were tabled due to a lack of sufficient science and data regarding potential side effects [4] Potential Confusion & Uncertainty - The new recommendations may cause confusion for the general public regarding whether or not they should get a COVID vaccine [3] - The timeframe for the acting CDC director to sign off on the recommendations is currently unclear [4]